The Clinical and Laboratory Characteristics of Recurrent Drug- Related Hyponatremia
NCT01509170 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2012-01-12
Summary
The aim of this study is to identify factors associated with hyponatremia among patients hospitalized in the internal medicine ward. Consequtive patients hospitalized because of hyponatremia will be recruited. Follow up will include clinical factors such as background diseases, complete drug history, blood tests including Biochemistry tests (Sodium, renal function), endocrinological evaluation, thyroid function tests, cortisol,urinary sodium on addmition. One month following discharge follow up Sodium level will be taken.
Conditions
- Hyponatremia
- SIADH
Sponsors & Collaborators
-
Hadassah Medical Organization
lead OTHER
Principal Investigators
-
Mordechai Muszkat, MD · Hadassah Medical Organization
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-02-29
- Primary Completion
- 2015-01-31
- Completion
- 2017-01-31
Countries
- Israel
Study Locations
More Related Trials
-
Targeted Correction of Plasma Sodium Levels in Hospitalized Patients With Hyponatremia
NCT03557957 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
NCT00264914 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia
NCT00435591 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia
NCT01507727 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Safety and Efficacy of Conivaptan in Hyponatremic Patients With Symptomatic Acute Decompensated Heart Failure (ADHF)
NCT00843986 ·Status: TERMINATED ·Phase: PHASE3
-
Urea for Chronic Hyponatremia
NCT04588207 ·Status: TERMINATED ·Phase: PHASE2
-
Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic Hyponatremia
NCT00380575 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia
NCT00728091 ·Status: TERMINATED ·Phase: PHASE3
-
Water Load Test Value for Hyponatremia
NCT04256499 ·Status: COMPLETED
-
Aquaresis Utility for Hyponatremic Acute Heart Failure Study
NCT02183792 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Tolvaptan in Cirrhotic Patients With Hyponatremia
NCT01850940 ·Status: COMPLETED
-
Factors Associated With Hyponatremia Induced by High-dose Cyclophosphamide
NCT02399358 ·Status: UNKNOWN
-
A Multicenter Trial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADH
NCT03048747 ·Status: COMPLETED ·Phase: PHASE3
-
Saline Infusion Test in Hyponatremia
NCT06498856 ·Status: NOT_YET_RECRUITING
-
Changes in Serum Creatinine Levels Can Help Distinguish Hypovolemic From Euvolemic Hyponatremia
NCT04744987 ·Status: COMPLETED
-
An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia
NCT00379847 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
NCT00032734 ·Status: COMPLETED ·Phase: PHASE2
-
Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium
NCT05188131 ·Status: COMPLETED ·Phase: PHASE4
-
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Oral Lixivaptan Capsules in Subject With Euvolemic Hyponatremia
NCT00660959 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of the SGLT2-inhibitor Empagliflozin on Patients With Chronic SIADH - the SANDx Study
NCT03202667 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Asymptomatic Bacteriuria, Hyponatremia and Geri-atric Syndrome
NCT05055856 ·Status: COMPLETED ·Phase: NA
-
Comparison of Single and Combination Diuretics in Low-Renin Hypertension
NCT02351973 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients
NCT00684164 ·Status: WITHDRAWN ·Phase: PHASE3
-
Safety and Efficacy of Hydrochlorothiazide in the Treatment of Hypernatremia in Critically Ill Patients
NCT03658850 ·Status: UNKNOWN ·Phase: PHASE2
-
The Role of Skin Sodium Accumulation in Chronic Kidney Disease
NCT07020104 ·Status: RECRUITING ·Phase: NA